Artiva Biotherapeutics In...

NASDAQ: ARTV · Real-Time Price · USD
2.77
0.07 (2.59%)
At close: Aug 15, 2025, 3:59 PM
2.75
-0.54%
After-hours: Aug 15, 2025, 04:10 PM EDT

Artiva Biotherapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
251K 33.49M 4.93M 2M
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
251K 33.49M 4.93M 2M
Operating Income
-67.28M -30.67M -59.83M -53.27M
Interest Income
5.35M 2.54M 1.29M n/a
Pretax Income
-58.49M -27.62M -58.34M -71.83M
Net Income
-58.49M -27.7M -58.39M -71.83M
Selling & General & Admin
17.2M 13.91M 20.78M 12.86M
Research & Development
50.33M 50.25M 43.98M 42.41M
Other Expenses
n/a n/a 200K n/a
Operating Expenses
67.53M 64.16M 64.76M 55.27M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
67.53M 64.16M 64.76M 55.27M
Income Tax Expense
n/a 72K 53K n/a
Shares Outstanding (Basic)
11.26M 23.28M 17.58M 17.58M
Shares Outstanding (Diluted)
11.26M 23.28M 17.58M 17.58M
EPS (Basic)
-5.2 -1.19 -3.32 -4.08
EPS (Diluted)
-5.2 -1.19 -3.32 -4.08
EBITDA
-64.85M -28.41M -58.67M -71.58M
EBIT
-67.28M -30.67M -59.83M -71.83M
Depreciation & Amortization
2.43M 2.27M 1.16M 248K